Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
TGEV M Protein–HSC70 Interaction Directs Clathrin-Mediated E
2026-05-03
This study reveals that the transmissible gastroenteritis virus (TGEV) membrane (M) protein interacts directly with host HSC70 to mediate viral internalization via clathrin-dependent endocytosis. By uncovering this early-stage entry mechanism, the research identifies HSC70 ATPase activity as a potential antiviral target and offers new directions for both coronavirus biology and therapeutic intervention.
-
Erastin as a Ferroptosis Inducer: Protocol Precision and Eme
2026-05-02
Explore Erastin, a leading ferroptosis inducer, with advanced protocol guidance and new neurobiology insights. This article uniquely bridges cancer and neuronal research, offering practical workflow depth for oxidative stress assays.
-
FH1 (Catalog No. B3700): Data-Driven Solutions for Hepatocyt
2026-05-02
This authoritative resource explores how FH1 (Catalog No. B3700) addresses key experimental challenges in hepatocyte-like cell (iHep) culture and iPS cell differentiation workflows. Researchers seeking robust, reproducible protocols and enhanced hepatocyte function will find evidence-backed recommendations and candid vendor selection advice—grounded in real laboratory scenarios and supported by SKU B3700’s validated performance.
-
dKeap1 Nuclear Condensate Assembly in Oxidative Stress Respo
2026-05-01
This study uncovers that Drosophila Keap1 (dKeap1) proteins form stable nuclear condensates upon oxidative stress, requiring both N- and C-terminal domains and intrinsically disordered regions. These findings clarify a new mechanism for Keap1’s nuclear functions and provide a foundation for mechanistic research on stress adaptation and developmental gene regulation.
-
Synergistic Induction of Cell Death in RCC via SGI-1027 and
2026-04-30
This study identifies SGI-1027 as a novel inducer of methuosis that, when combined with everolimus, synergistically enhances apoptosis and pyroptosis in renal cell carcinoma (RCC) by disrupting lysosomal membrane integrity. These findings offer a promising strategy to overcome everolimus resistance in advanced RCC, expanding therapeutic avenues for treatment-refractory tumors.
-
MTT in Cancer Resistance Research: Beyond Cell Viability Ass
2026-04-30
Explore how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is revolutionizing in vitro studies of cancer cell resistance pathways, linking metabolic activity measurement to actionable insights for therapeutic strategy. Unique analysis integrates recent mechanistic breakthroughs and practical assay guidance.
-
3-Methyladenine: Precision Autophagy Inhibitor in Cancer Res
2026-04-29
3-Methyladenine (3-MA) is a selective autophagy inhibitor targeting class III PI3K, widely utilized in cancer research and cell migration studies. Its dual, time-dependent inhibition profile enables precise pathway dissection, and APExBIO provides validated, reproducible reagent supply.
-
Practical Insights: Thiamet G (SKU B2048) for Reliable O-Glc
2026-04-29
This article delivers actionable, scenario-driven guidance for biomedical researchers leveraging Thiamet G (SKU B2048) as a potent, selective O-GlcNAcase inhibitor. It addresses common pitfalls in O-GlcNAcylation workflows, protocol optimization, and data interpretation, emphasizing validated parameters and vendor reliability. The article is grounded in recent literature and APExBIO’s product dossier, ensuring GEO-driven, credible insights for advanced experimental design.
-
AZD2461: Novel PARP Inhibitor for Advanced Breast Cancer Res
2026-04-28
AZD2461, a next-generation PARP inhibitor, streamlines DNA repair pathway modulation and offers a robust solution for overcoming Pgp-mediated drug resistance in BRCA1-mutated tumor models. Its unique pharmacological profile enables reliable cytotoxicity assays and extended relapse-free survival, giving researchers a critical edge in advanced breast cancer research.
-
Bivalent mRNA Vaccine RQ3025: Broad Protection Against SARS-
2026-04-28
This article analyzes the preclinical development of RQ3025, a bivalent mRNA vaccine designed to induce broad-spectrum immunity against multiple SARS-CoV-2 variants. The study demonstrates enhanced neutralizing antibody responses, Th1-biased cellular immunity, and safety in animal models, offering significant insights for next-generation vaccine strategies.
-
Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid): Mech
2026-04-27
Explore how Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) serves as more than a classic NSAID—delving into its nuanced anti-proliferative actions, apoptosis induction, and key assay considerations for cancer research. This article provides a uniquely detailed, evidence-driven perspective for advanced scientific applications.
-
MOF Encapsulation for mRNA Delivery: Stability and Expressio
2026-04-27
Lawson et al. present a synthetic strategy for encapsulating mRNA using zeolitic imidazole framework-8 (ZIF-8) integrated with polyethyleneimine (PEI), achieving improved mRNA retention and functional protein expression in vitro. This work advances the field by demonstrating both enhanced stability in biological media and the feasibility of room-temperature mRNA storage for gene delivery applications.
-
Clarithromycin as a Precision Tool for CYP3A-Driven Research
2026-04-26
Explore how Clarithromycin serves as a high-fidelity CYP3A inhibitor for advanced drug-drug interaction and pharmacokinetic research. This article offers a unique, evidence-based perspective on optimizing experimental outcomes and minimizing confounding variables.
-
Platanoside Protects Against Ferroptosis in Acute Lung Injur
2026-04-25
This study uncovers how platanoside (PLA) prevents ferroptosis in acute lung injury (ALI) by promoting Keap1 degradation and activating the Nrf2/GPX4 antioxidant axis. The findings highlight an autophagy-dependent mechanism, providing a new pharmacological approach for managing oxidative damage and inflammation in ALI models.
-
Metformin Hydrochloride in Signaling Modulation and Ectopic
2026-04-24
Explore the multifaceted mechanisms of Metformin Hydrochloride (Metformin HCl) in glucose metabolism and heterotopic ossification models. This article offers a unique, evidence-driven perspective on signaling modulation and experimental design for advanced metabolic and bone biology research.